One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

BACKGROUND: Secondary hyperparathyroidism (sHPT), a common complication of chronic kidney disease, is characterized by elevated serum parathyroid hormone (PTH). Etelcalcetide is an intravenous calcimimetic that increases sensitivity of the calcium-sensing receptor to calcium and decreases PTH secret...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nephrol Dial Transplant
Autors principals: Bushinsky, David A, Chertow, Glenn M, Cheng, Sunfa, Deng, Hongjie, Kopyt, Nelson, Martin, Kevin J, Rastogi, Anjay, Ureña-Torres, Pablo, Vervloet, Marc, Block, Geoffrey A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538239/
https://ncbi.nlm.nih.gov/pubmed/30859218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfz039
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars